Prognostic value of high sensitivity C-reaction protein in non-insulin dependent diabetes mellitus patients with non-alcoholic fatty liver disease.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  International Journal of Clinical and Experimental Pathology

• Publication date

  2015-07-01

• Fields of study

  Medicine

• Identifiers
  PMID 26339423PMCID PMC4555751
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Admission C-reactive protein and short- as well as long-term mortality in diabetic versus non-diabetic patients with incident myocardial infarction

  2010cited by this paper
• Insulin resistance in Chinese patients with type 2 diabetes is associated with C-reactive protein independent of abdominal obesity

  2010cited by this paper
• Preoperative NT-proBNP and CRP predict perioperative major cardiovascular events in non-cardiac surgery

  2010cited by this paper
• Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years

  2010cited by this paper
• Preoperative NT-proBNP and CRP predict perioperative major cardiovascular events in non-cardiac surgery

  2009cited by this paper
• Obesity, coffee consumption and CRP levels in postmenopausal overweight/obese women: Importance of hormone replacement therapy use

  2009cited by this paper
• Carotid plaque, stroke pathogenesis, and CRP: Treatment of ischemic stroke

  2008cited by this paper
• Definition and natural history of metabolic steatosis: clinical aspects of NAFLD, NASH and cirrhosis.

  2008cited by this paper
• Obesity and C‐reactive Protein Levels Among White, Black, and Hispanic US Adults

  2008cited by this paper
• Inflammation and insulin resistance

  2008cited by this paper
• Effect of lifestyle intervention on non-alcoholic fatty liver disease in Chinese obese children.

  2008cited by this paper
• Epidemiology and natural history of NAFLD and NASH.

  2007cited by this paper
• Use of high-sensitivity CRP to predict first cardiovascular events.

  2007cited by this paper
• Carotid plaque, stroke pathogenesis, and CRP: Treatment of ischemic stroke

  2007cited by this paper
• Genetic variants of adiponectin receptor 2 are associated with increased adiponectin levels and decreased triglyceride/VLDL levels in patients with metabolic syndrome

  2006cited by this paper
• Value of serum glycated albumin and high-sensitivity C-reactive protein levels in the prediction of presence of coronary artery disease in patients with type 2 diabetes

  2006cited by this paper
• Increased levels of C-reactive protein and fibrinogen influence the risk of vascular events in patients with NIDDM.

  2006cited by this paper
• C-reactive protein as predictor of death in end-stage diabetic nephropathy: role of peripheral arterial disease.

  2005cited by this paper
• Mechanism of Hepatic Insulin Resistance in Non-alcoholic Fatty Liver Disease*

  2004cited by this paper
• Non-alcoholic steatohepatitis

  2004cited by this paper
• Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): diagnosis and clinical course.

  2004cited by this paper
• Early Use of Beta-Blockers Is Associated with Attenuation of Serum C-Reactive Protein Elevation and Favorable Short-Term Prognosis after Acute Myocardial Infarction

  2003cited by this paper
• Endothelial function, inflammation, and prognosis in cardiovascular disease.

  2003cited by this paper
• Prevalence of nonalcoholic fatty liver among administrative officers in Shanghai: an epidemiological survey.

  2003cited by this paper
• NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome

  2002cited by this paper

• Efecto de semaglutida sobre los biomarcadores de la enfermedad del hígado graso en pacientes con diabetes y obesidad

  2023cites this paper
• Effect of semaglutide on fatty liver disease biomarkers in patients with diabetes and obesity.

  2022cites this paper
• Effect of semaglutide on liver enzymes and markers of inflammation in subjects with type 2 diabetes and/or obesity

  2019cites this paper
• Effects of SGLT2 inhibitors on systemic and tissue low-grade inflammation: The potential contribution to diabetes complications and cardiovascular disease.

  2018cites this paper
• Should adults with diabetes mellitus be vaccinated against hepatitis B virus? A systematic review of diabetes mellitus and the progression of hepatitis B disease

  2017cites this paper
• Clinical features of nonalcoholic fatty liver disease assoсiated with type 2 diabetes

  2016cites this paper
• Parabolic relationship between sex-specific serum high sensitive C reactive protein and non-alcoholic fatty liver disease in chinese adults: a large population-based study

  2016influential citation
• Inhibitory effects and mechanism of 25-OH-PPD on glomerular mesangial cell proliferation induced by high glucose.

  2016cites this paper